使用国家癌症数据库来识别癌症治疗中的差异
Fatima Mubarak1, Emmanuel M Gabriel2, Jade C Bowers3
1Aga Khan University, Karachi, Pakistan.
The American surgeon
|March 25, 2025
概括
国家癌症数据库 (NCDB) 提供了有关美国癌症护理差异的宝贵见解. 研究人员必须了解它的优点和局限性,以准确分析癌症的结果.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 生物统计学 生物统计学
背景情况:
- 国家癌症数据库 (NCDB) 是美国癌症研究的一个重要资源.
- 许多研究利用NCDB调查癌症护理和患者治疗结果的差异.
- 了解NCDB的细微差别对于对癌症不平等的有效研究至关重要.
研究的目的:
- 审查国家癌症数据库 (NCDB) 的优势,以研究癌症差异.
- 在检查癌症护理和结果时概述NCDB的局限性.
- 引导研究人员有效和批判性地使用NCDB进行差异研究.
主要方法:
- 对利用NCDB进行癌症差异研究的研究进行文献综述.
- 对NCDB数据集记录的优点和局限性的分析.
- 综合发现,为研究人员提供建议.
主要成果:
- 美国癌症监督委员会 (NCDB) 提供了关于美国癌症患者护理的庞大,全面的数据集.
- 确定的优势包括其广泛的患者数量和治疗数据.
- 关键的局限性包括潜在的数据偏差和特定患者人群代表性.
结论:
- 国家癌症控制委员会 (NCDB) 是探索癌症差异的强大工具,但其应用需要仔细考虑其固有的局限性.
- 研究人员在解释NCDB调查结果时应该意识到潜在的偏见和数据完整性问题.
- 承认NCDB的优点和弱点可以提高癌症差异研究的严谨性和有效性.
相关概念视频
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


